No Data
No Data
Those Who Invested in Krystal Biotech (NASDAQ:KRYS) Five Years Ago Are up 329%
Long term investing can be life changing when you buy and hold the truly great businesses. While the best companies are hard to find, but they can generate massive returns over long periods. Just th
Catalyst Watch: HP Enterprise Event, Walmart+ Week, Pure Storage Buzz, and Triple-witching Volatility
Krystal Biotech Insider Sold Shares Worth $8,788,062, According to a Recent SEC Filing
Suma Krishnan, 10% Owner, Director, President, Research & Development, on June 11, 2024, sold 50,000 shares in Krystal Biotech (KRYS) for $8,788,062. Following the Form 4 filing with the SEC, Krishnan
Krystal Biotech(KRYS.US) 10% Shareholder Sells US$8.79 Million in Common Stock
$Krystal Biotech(KRYS.US)$ 10% Shareholder Krishnan Krish S sold 50,000 shares of common stock on Jun 11, 2024 at an average price of $175.7612 for a total value of $8.79 million. This transaction inv
Form 144 | Krystal Biotech(KRYS.US) Director Proposes to Sell 4.42 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 11, $Krystal Biotech(KRYS.US)$ Director SUMA KRISHNAN intends to sell 25,000 shares of its common stock on Jun 11, with a total market value of approximately $4.42 million.
Top Gap Ups and Downs on Monday: KKR, CRWD, DEO and More
Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.
No Data